Autonomous Therapeutics Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
Autonomous Therapeutics was founded in 2017 by a team from Harvard Medical School and UCSF. We're developing new classes of target-activated (and resistance-proof) medicines from influenza to colon cancer. Our technology is built around a simple idea: precision nucleic acids that sense and only activate in diseased cells, avoiding healthy cells. Reach out with a CV if you're interested in learning more and joining us!